STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical company focused on mental health disorder treatments, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference. The event will take place in Boston, MA from August 13-15, 2024.

Key details of atai's involvement include:

  • A fireside chat scheduled for Wednesday, August 14 at 11:00 A.M. EDT
  • One-on-one investor meetings
  • A webcast link provided for remote access

An archived replay of the fireside chat will be available on the Investors section of atai's website under Events for up to 90 days following the conference.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

NEW YORK and BERLIN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that the Company’s management team is scheduled to participate in the Canaccord Genuity 44th Annual Growth Conference taking place in Boston, MA from August 13-15, 2024. Details of the company’s participation:

Format: Fireside chat and 1x1 investor meetings
Date and Time: Fireside chat on Wednesday August 14 at 11:00 A.M. EDT
Webcast link: Here

An archived replay will be available on the Investors section of the atai website under Events for up to 90 days.

About atai Life Sciences

atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders. By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines to achieve clinically meaningful and sustained behavioral change in mental health patients. atai's vision is to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit www.atai.life.

Contact Information

Investor Contact:

IR@atai.life

Media Contact:

PR@atai.life


FAQ

When is atai Life Sciences (ATAI) participating in the Canaccord Genuity Growth Conference?

atai Life Sciences (ATAI) is participating in the Canaccord Genuity 44th Annual Growth Conference from August 13-15, 2024, with a fireside chat scheduled for Wednesday, August 14 at 11:00 A.M. EDT.

What type of events will atai Life Sciences (ATAI) be involved in at the Canaccord conference?

atai Life Sciences (ATAI) will be involved in a fireside chat and one-on-one investor meetings at the Canaccord Genuity 44th Annual Growth Conference.

How can investors access atai Life Sciences' (ATAI) presentation at the Canaccord conference?

Investors can access atai Life Sciences' (ATAI) presentation via a webcast link provided by the company. An archived replay will also be available on the Investors section of atai's website for up to 90 days after the event.

Where is the Canaccord Genuity 44th Annual Growth Conference being held?

The Canaccord Genuity 44th Annual Growth Conference is being held in Boston, MA.
Atai Beckley Inc

NASDAQ:ATAI

ATAI Rankings

ATAI Latest News

ATAI Latest SEC Filings

ATAI Stock Data

1.38B
348.33M
7.7%
39.81%
8.03%
Biotechnology
Pharmaceutical Preparations
Link
Germany
AMSTELVEEN